Recombinant 2019-nCoV Nucleocapsid Protein (His Tag)

Recombinant 2019-nCoV Nucleocapsid Protein is produced by our E.coli expression system and the target gene encoding Met1-Ala419 is expressed with a 6His tag at the N-terminus.

Introducing the Recombinant 2019-nCoV Nucleocapsid Protein (His Tag), a cutting-edge product meticulously designed to cater to the needs of scientific research and diagnostic applications. This protein, derived from the novel coronavirus (2019-nCoV), showcases exceptional purity and quality, making it an indispensable tool for various laboratory investigations.

Crafted with utmost precision, the Recombinant 2019-nCoV Nucleocapsid Protein (His Tag) exhibits a high affinity for histidine residues, enabling facile purification and subsequent downstream applications. Its recombinant nature ensures consistency and reliability, allowing researchers to obtain reproducible results with utmost confidence.

This protein serves as a vital component in the study of the 2019-nCoV virus, aiding in the elucidation of its structure, function, and interactions with host cells. Its utilization extends to the development and validation of diagnostic assays, facilitating the accurate detection and monitoring of the virus in clinical samples.

The Recombinant 2019-nCoV Nucleocapsid Protein (His Tag) is manufactured under stringent quality control measures, ensuring its exceptional purity, stability, and bioactivity. It is supplied in a convenient lyophilized form, preserving its integrity and facilitating ease of storage and transportation.

With its remarkable attributes and versatile applications, the Recombinant 2019-nCoV Nucleocapsid Protein (His Tag) stands as an invaluable asset for researchers and diagnostic professionals alike, empowering them to advance their understanding of the 2019-nCoV virus and contribute to the global efforts in combating this unprecedented health challenge.